190 related articles for article (PubMed ID: 18493581)
1. A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.
Vandepoele K; Andries V; Van Roy N; Staes K; Vandesompele J; Laureys G; De Smet E; Berx G; Speleman F; van Roy F
PLoS One; 2008 May; 3(5):e2207. PubMed ID: 18493581
[TBL] [Abstract][Full Text] [Related]
2. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
Andries V; Vandepoele K; Staes K; Berx G; Bogaert P; Van Isterdael G; Ginneberge D; Parthoens E; Vandenbussche J; Gevaert K; van Roy F
BMC Cancer; 2015 May; 15():391. PubMed ID: 25958384
[TBL] [Abstract][Full Text] [Related]
3. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
4. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma.
Laureys G; Versteeg R; Speleman F; van der Drift P; Francke U; Opdenakker G; Van Roy N
Eur J Cancer; 1995; 31A(4):523-6. PubMed ID: 7576958
[TBL] [Abstract][Full Text] [Related]
6. The NBPF1 promoter has been recruited from the unrelated EVI5 gene before simian radiation.
Vandepoele K; Andries V; van Roy F
Mol Biol Evol; 2009 Jun; 26(6):1321-32. PubMed ID: 19282512
[TBL] [Abstract][Full Text] [Related]
7. Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36.
van der Drift P; Chan A; Laureys G; van Roy N; Sickmann G; den Dunnen J; Westerveld A; Speleman F; Versteeg R
Genes Chromosomes Cancer; 1995 Sep; 14(1):35-42. PubMed ID: 8527382
[TBL] [Abstract][Full Text] [Related]
8. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.
Van Roy N; Vandesompele J; Berx G; Staes K; Van Gele M; De Smet E; De Paepe A; Laureys G; van der Drift P; Versteeg R; Van Roy F; Speleman F
Genes Chromosomes Cancer; 2002 Oct; 35(2):113-20. PubMed ID: 12203774
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.
Van Roy N; Laureys G; Van Gele M; Opdenakker G; Miura R; van der Drift P; Chan A; Versteeg R; Speleman F
Eur J Cancer; 1997 Oct; 33(12):1974-8. PubMed ID: 9516836
[TBL] [Abstract][Full Text] [Related]
11. Molecular and genetic studies on the region of translocation and duplication in the neuroblastoma cell line NGP at the 1p36.13-p36.32 chromosomal site.
Casciano I; Marchi JV; Muresu R; Volpi EV; Rozzo C; Opdenakker G; Romani M
Oncogene; 1996 May; 12(10):2101-8. PubMed ID: 8668335
[TBL] [Abstract][Full Text] [Related]
12. [The neuroblastoma, "enfant terrible" among pediatric tumors].
Laureys G
Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
[TBL] [Abstract][Full Text] [Related]
13. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular studies on the neuroblastoma cell line NGP: identification of a reciprocal t(1;15) involving the "consensus region" 1p36.1.
Muresu R; Casciano I; Volpi EV; Siniscalco M; Romani M
Genes Chromosomes Cancer; 1995 May; 13(1):66-71. PubMed ID: 7541646
[TBL] [Abstract][Full Text] [Related]
15. A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.
Vandepoele K; Van Roy N; Staes K; Speleman F; van Roy F
Mol Biol Evol; 2005 Nov; 22(11):2265-74. PubMed ID: 16079250
[TBL] [Abstract][Full Text] [Related]
16. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma.
Laureys G; Speleman F; Opdenakker G; Benoit Y; Leroy J
Genes Chromosomes Cancer; 1990 Sep; 2(3):252-4. PubMed ID: 2078517
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
Van Roy N; Cheng NC; Laureys G; Opdenakker G; Versteeg R; Speleman F
Eur J Cancer; 1995; 31A(4):530-5. PubMed ID: 7576960
[TBL] [Abstract][Full Text] [Related]
18. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
19. Identical chromosome 1p breakpoint abnormality in both the tumor and the constitutional karyotype of a patient with neuroblastoma.
Lampert F; Rudolph B; Christiansen H; Franke F
Cancer Genet Cytogenet; 1988 Sep; 34(2):235-9. PubMed ID: 3165695
[TBL] [Abstract][Full Text] [Related]
20. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
